{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:54:49Z","timestamp":1792659289692,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s00415-013-7051-7","type":"journal-article","created":{"date-parts":[[2013,8,21]],"date-time":"2013-08-21T14:06:39Z","timestamp":1377093999000},"page":"2802-2814","source":"Crossref","is-referenced-by-count":304,"title":["Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy"],"prefix":"10.1007","volume":"260","author":[{"given":"Teresa","family":"Coelho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis F.","family":"Maia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Martins","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rcia W.","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violaine","family":"Plant\u00e9-Bordeneuve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole B.","family":"Suhr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Concei\u00e7ao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut H.-J.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Trigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery W.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Labaudini\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Packman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna R.","family":"Grogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,22]]},"reference":[{"issue":"3","key":"7051_CR1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3109\/13506120308998998","volume":"10","author":"LH Connors","year":"2003","unstructured":"Connors LH, Lim A, Prokaeva T, Roskens VA, Costello CE (2003) Tabulation of human transthyretin (TTR) variants. Amyloid 10(3):160\u2013184","journal-title":"Amyloid"},{"issue":"7","key":"7051_CR2","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/archneur.62.7.1057","volume":"62","author":"Y Ando","year":"2005","unstructured":"Ando Y, Nakamura M, Araki S (2005) Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol 62(7):1057\u20131062","journal-title":"Arch Neurol"},{"issue":"1","key":"7051_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-2836(74)90291-5","volume":"88","author":"CC Blake","year":"1974","unstructured":"Blake CC, Geisow MJ, Swan ID, Rerat C, Rerat B (1974) Structure of human plasma prealbumin at 2\u20135\u00a0A resolution. A preliminary report on the polypeptide chain conformation, quaternary structure and thyroxine binding. J Mol Biol 88(1):1\u201312","journal-title":"J Mol Biol"},{"issue":"5213","key":"7051_CR4","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.7754382","volume":"268","author":"HL Monaco","year":"1995","unstructured":"Monaco HL, Rizzi M, Coda A (1995) Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein. Science 268(5213):1039\u20131041","journal-title":"Science"},{"issue":"Suppl 4","key":"7051_CR5","doi-asserted-by":"crossref","first-page":"16427","DOI":"10.1073\/pnas.202495199","volume":"99","author":"P Hammarstr\u00f6m","year":"2002","unstructured":"Hammarstr\u00f6m P, Jiang X, Hurshman AR, Powers ET, Kelly JW (2002) Sequence-dependent denaturation energetics: a major determinant in amyloid disease diversity. Proc Natl Acad Sci USA 99(Suppl 4):16427\u201316432","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"7051_CR6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1212\/01.WNL.0000132966.36437.12","volume":"63","author":"H Koike","year":"2004","unstructured":"Koike H, Misu K, Sugiura M, Iijima M, Mori K, Yamamoto M, Hattori N, Mukai E, Ando Y, Ikeda S, Sobue G (2004) Pathology of early- vs late-onset TTR Met30 familial amyloid polyneuropathy. Neurology 63(1):129\u2013138","journal-title":"Neurology"},{"key":"7051_CR7","first-page":"1","volume":"590","author":"R Andersson","year":"1976","unstructured":"Andersson R (1976) Familial amyloidosis with polyneuropathy. A clinical study based on patients living in northern Sweden. Acta Med Scand Suppl 590:1\u201364","journal-title":"Acta Med Scand Suppl"},{"key":"7051_CR8","unstructured":"Coutinho P, Martins da Silva A, Lopes Lima J, Resende Barbosa A (1980) Forty years of experience with type I amyloid neuropathy: review of 483 cases. In: Glenner GG, Pinho e Costa P, Falcao de Freitas A (eds) Amyloid and amyloidosis. Excerpta Medica, Amsterdam, pp 88\u221298"},{"issue":"3","key":"7051_CR9","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1212\/WNL.51.3.708","volume":"51","author":"V Plant\u00e9-Bordeneuve","year":"1998","unstructured":"Plant\u00e9-Bordeneuve V, Lalu T, Misrahi M, Reilly MM, Adams D, Lacroix C, Said G (1998) Genotypic-phenotypic variations in a series of 65 patients with familial amyloid polyneuropathy. Neurology 51(3):708\u2013714","journal-title":"Neurology"},{"issue":"30","key":"7051_CR10","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.2174\/138161208786404155","volume":"14","author":"Y Sekijima","year":"2008","unstructured":"Sekijima Y, Kelly JW, Ikeda S (2008) Pathogenesis of and therapeutic strategies to ameliorate the transthyretin amyloidoses. Curr Pharm Des 14(30):3219\u20133230","journal-title":"Curr Pharm Des"},{"issue":"8853","key":"7051_CR11","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/0140-6736(93)93127-M","volume":"341","author":"G Holmgren","year":"1993","unstructured":"Holmgren G, Ericzon BG, Groth CG, Steen L, Suhr O, Andersen O, Wallin BG, Seymour A, Richardson S, Hawkins PN et al (1993) Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 341(8853):1113\u20131116","journal-title":"Lancet"},{"issue":"4","key":"7051_CR12","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1212\/WNL.47.4.944","volume":"47","author":"PR Bergethon","year":"1996","unstructured":"Bergethon PR, Sabin TD, Lewis D, Simms RW, Cohen AS, Skinner M (1996) Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation. Neurology 47(4):944\u2013951","journal-title":"Neurology"},{"issue":"1","key":"7051_CR13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/01.TP.0000092307.98347.CB","volume":"77","author":"G Herlenius","year":"2004","unstructured":"Herlenius G, Wilczek HE, Larsson M, Ericzon BG (2004) Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the Familial Amyloidotic Polyneuropathy World Transplant Registry. Transplantation 77(1):64\u201371","journal-title":"Transplantation"},{"issue":"11","key":"7051_CR14","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.2169\/internalmedicine.44.1151","volume":"44","author":"Y Takei","year":"2005","unstructured":"Takei Y, Ikeda S, Ikegami T, Hashikura Y, Miyagawa S, Ando Y (2005) Ten years of experience with liver transplantation for familial amyloid polyneuropathy in Japan: outcomes of living donor liver transplantations. Intern Med 44(11):1151\u20131156","journal-title":"Intern Med"},{"issue":"10","key":"7051_CR15","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/lt.21817","volume":"15","author":"S Okamoto","year":"2009","unstructured":"Okamoto S, Wixner J, Obayashi K, Ando Y, Ericzon BG, Friman S, Uchino M, Suhr OB (2009) Liver transplantation for familial amyloidotic polyneuropathy: impact on Swedish patients\u2019 survival. Liver Transpl 15(10):1229\u20131235","journal-title":"Liver Transpl"},{"issue":"5","key":"7051_CR16","first-page":"2679","volume":"26","author":"M Winkler","year":"1994","unstructured":"Winkler M, Brinkmann C, Jost U, Oldhafer K, Ringe B, Pichlmayr R (1994) Long-term side effects of cyclosporine-based immunosuppression in patients after liver transplantation. Transpl Proc 26(5):2679\u20132682","journal-title":"Transpl Proc"},{"issue":"2","key":"7051_CR17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00007890-199807270-00016","volume":"66","author":"AJ Stangou","year":"1998","unstructured":"Stangou AJ, Hawkins PN, Heaton ND, Rela M, Monaghan M, Nihoyannopoulos P, O\u2019Grady J, Pepys MB, Williams R (1998) Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: implications for amyloid fibrillogenesis. Transplantation 66(2):229\u2013233","journal-title":"Transplantation"},{"issue":"1","key":"7051_CR18","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/01.TP.0000133517.20972.27","volume":"78","author":"R H\u00f6rnsten","year":"2004","unstructured":"H\u00f6rnsten R, Wiklund U, Olofsson BO, Jensen SM, Suhr OB (2004) Liver transplantation does not prevent the development of life-threatening arrhythmia in familial amyloidotic polyneuropathy, Portuguese-type (ATTR Val30Met) patients. Transplantation 78(1):112\u2013116","journal-title":"Transplantation"},{"issue":"4","key":"7051_CR19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/13506120701614032","volume":"14","author":"JJ Liepnieks","year":"2007","unstructured":"Liepnieks JJ, Benson MD (2007) Progression of cardiac amyloid deposition in hereditary transthyretin amyloidosis patients after liver transplantation. Amyloid 14(4):277\u2013282","journal-title":"Amyloid"},{"issue":"1","key":"7051_CR20","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1600-6143.2006.01585.x","volume":"7","author":"M Yazaki","year":"2007","unstructured":"Yazaki M, Mitsuhashi S, Tokuda T, Kametani F, Takei YI, Koyama J, Kawamorita A, Kanno H, Ikeda SI (2007) Progressive wild-type transthyretin deposition after liver transplantation preferentially occurs onto myocardium in FAP patients. Am J Transpl 7(1):235\u2013242","journal-title":"Am J Transpl"},{"issue":"1\u20132","key":"7051_CR21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jns.2009.05.001","volume":"284","author":"G Said","year":"2009","unstructured":"Said G, Plant\u00e9-Bordeneuve V (2009) Familial amyloid polyneuropathy: a clinico-pathologic study. J Neurol Sci 284(1\u20132):149\u2013154","journal-title":"J Neurol Sci"},{"issue":"12","key":"7051_CR22","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1021\/ar020073i","volume":"38","author":"SM Johnson","year":"2005","unstructured":"Johnson SM, Wiseman RL, Sekijima Y, Green NS, Adamski-Werner SL, Kelly JW (2005) Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: a focus on the transthyretin amyloidoses. Acc Chem Res 38(12):911\u2013921","journal-title":"Acc Chem Res"},{"issue":"24","key":"7051_CR23","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1002\/anie.200351179","volume":"42","author":"H Razavi","year":"2003","unstructured":"Razavi H, Palaninathan SK, Powers ET, Wiseman RL, Purkey HE, Mohamedmohaideen NN, Deechongkit S, Chiang KP, Dendle MT, Sacchettini JC, Kelly JW (2003) Benzoxazoles as transthyretin amyloid fibril inhibitors: synthesis, evaluation, and mechanism of action. Angew Chem Int Ed Engl 42(24):2758\u20132761","journal-title":"Angew Chem Int Ed Engl"},{"issue":"24","key":"7051_CR24","doi-asserted-by":"crossref","first-page":"9629","DOI":"10.1073\/pnas.1121005109","volume":"109","author":"CE Bulawa","year":"2012","unstructured":"Bulawa CE, Connelly S, DeVit M, Wang L, Weigel C, Fleming JA, Packman J, Powers ET, Wiseman RL, Foss TR, Wilson IA, Kelly JW, Labaudini\u00e8re R (2012) Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade. Proc Natl Acad Sci USA 109(24):9629\u20139634","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"7051_CR25","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1212\/WNL.0b013e3182661eb1","volume":"79","author":"T Coelho","year":"2012","unstructured":"Coelho T, Maia LF, Martins da Silva A, Waddington Cruz M, Plant\u00e9-Bordeneuve V, Lozeron P, Suhr OB, Campistol JM, Concei\u00e7\u00e3o IM, Schmidt HH, Trigo P, Kelly JW, Labaudini\u00e8re R, Chan J, Packman J, Wilson A, Grogan DR (2012) Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial. Neurology 79(8):785\u2013792","journal-title":"Neurology"},{"issue":"1","key":"7051_CR26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1212\/WNL.49.1.229","volume":"49","author":"PJ Dyck","year":"1997","unstructured":"Dyck PJ, Davies JL, Litchy WJ, O\u2019Brien PC (1997) Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort. Neurology 49(1):229\u2013239","journal-title":"Neurology"},{"issue":"3","key":"7051_CR27","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1089\/dia.2005.7.497","volume":"7","author":"EJ Vinik","year":"2005","unstructured":"Vinik EJ, Hayes RP, Oglesby A, Bastyr E, Barlow P, Ford-Molvik SL, Vinik AI (2005) The development and validation of the Norfolk QOL-DN, a new measure of patients\u2019 perception of the effects of diabetes and diabetic neuropathy. Diabetes Technol Ther 7(3):497\u2013508","journal-title":"Diabetes Technol Ther"},{"issue":"5","key":"7051_CR28","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2796.1994.tb01106.x","volume":"235","author":"O Suhr","year":"1994","unstructured":"Suhr O, Danielsson A, Holmgren G, Steen L (1994) Malnutrition and gastrointestinal dysfunction as prognostic factors for survival in familial amyloidotic polyneuropathy. J Intern Med 235(5):479\u2013485","journal-title":"J Intern Med"},{"key":"7051_CR29","unstructured":"Wang L, Packman J, Labaudini\u00e8re R, Bulawa C (2006) Novel immunoturbidimetric method to monitor transthyretin (TTR) stability in plasma. Amyloid J Protein Fold Disord 13:(abstract) 67"},{"issue":"13","key":"7051_CR30","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1056\/NEJMsm0904209","volume":"361","author":"RB D\u2019Agostino","year":"2009","unstructured":"D\u2019Agostino RB (2009) The delayed-start study design. N Engl J Med 361(13):1304\u20131306","journal-title":"N Engl J Med"},{"key":"7051_CR31","doi-asserted-by":"crossref","unstructured":"Parkinson Study Group (2004) A controlled, randomized, delayed-start study of rasagiline in early Parkinson disease. Arch Neurol 61(4):561\u2013566","DOI":"10.1001\/archneur.61.4.561"},{"issue":"15","key":"7051_CR32","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1002\/mds.22218","volume":"23","author":"CW Olanow","year":"2008","unstructured":"Olanow CW, Hauser RA, Jankovic J, Langston W, Lang A, Poewe W, Tolosa E, Stocchi F, Melamed E, Eyal E, Rascol O (2008) A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson\u2019s disease (the ADAGIO study): rationale, design, and baseline characteristics. Mov Disord 23(15):2194\u20132201","journal-title":"Mov Disord"},{"issue":"13","key":"7051_CR33","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMoa0809335","volume":"361","author":"CW Olanow","year":"2009","unstructured":"Olanow CW, Rascol O, Hauser R, Feigin PD, Jankovic J, Lang A, Langston W, Melamed E, Poewe W, Stocchi F, Tolosa E (2009) A double-blind, delayed-start trial of rasagiline in Parkinson\u2019s disease. N Engl J Med 361(13):1268\u20131278","journal-title":"N Engl J Med"},{"issue":"1\u20132","key":"7051_CR34","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jns.2012.10.024","volume":"324","author":"JS Schneider","year":"2013","unstructured":"Schneider JS, Gollomp SM, Sendek S, Colcher A, Cambi F, Du W (2013) A randomized, controlled, delayed start trial of GM1 ganglioside in treated Parkinson\u2019s disease patients. J Neurol Sci 324(1\u20132):140\u2013148","journal-title":"J Neurol Sci"},{"key":"7051_CR35","first-page":"179","volume":"20","author":"T Coelho","year":"1993","unstructured":"Coelho T, Carvalho M, Saraiva MJ, Alves I, Almeida MR, Costa PP (1993) A strikingly benign evolution of FAP in an individual compound heterozygote for two TTR mutations: TTR Met30 and TTR Met119. J Rheumatol 20:179","journal-title":"J Rheumatol"},{"issue":"5607","key":"7051_CR36","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1126\/science.1079589","volume":"299","author":"P Hammarstr\u00f6m","year":"2003","unstructured":"Hammarstr\u00f6m P, Wiseman RL, Powers ET, Kelly JW (2003) Prevention of transthyretin amyloid disease by changing protein misfolding energetics. Science 299(5607):713\u2013716","journal-title":"Science"},{"issue":"9","key":"7051_CR37","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/00007890-199511150-00009","volume":"60","author":"OB Suhr","year":"1995","unstructured":"Suhr OB, Holmgren G, Steen L, Wikstr\u00f6m L, Norden G, Friman S, Duraj FF, Groth CG, Ericzon BG (1995) Liver transplantation in familial amyloidotic polyneuropathy. Follow-up of the first 20 Swedish patients. Transplantation 60(9):933\u2013938","journal-title":"Transplantation"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-013-7051-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-013-7051-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-013-7051-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T19:14:48Z","timestamp":1551208488000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-013-7051-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,22]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["7051"],"URL":"https:\/\/doi.org\/10.1007\/s00415-013-7051-7","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,22]]}}}